United States J&J Subsidiary Proposes Paying About USD 6.48B Over 25 years To Settle Talc Lawsuits BY Associated Press
National Explained: Why Maharashtra Stopped Johnson & Johnson Baby Powder's Sale, HC Ruling And Other Controversies BY Outlook Web Desk
National Bombay HC Allows Johnson & Johnson To Continue Manufacturing Baby Powder But Disallows Sale Till Further Orders BY PTI
National Explained: Johnson & Johnson To Stop Selling Talc Baby Powder, The Talc Controversy, And Alleged Talc-Cancer Link BY Madhur Sharma
Making A Difference Covid-19 Vaccines: US CDC Panel Recommends Pfizer, Moderna Over J&J Shot BY Outlook Web Desk
Making A Difference US Regulators Approve Covid-19 Vaccine Boosters For All Adults BY Outlook Web Desk
National Covaxin Gets WHO Nod For Emergency Use: What That Means For Indian Travelers BY Outlook Web Desk
Making A Difference US May Recommend Boosters Eight Months After Second Covid Vaccine Dose BY Associated Press
National Johnson & Johnson Hopeful About Getting EUA Of It's Single-Dose COVID Vaccine In India BY Outlook Web Desk
Making A Difference 'Not One Dose... ': Africa's Covid-19 Envoy Blasts EU, COVAX Over Vaccine Crisis BY Associated Press
Making A Difference Welcome Back! Now Work Out The Rules: Says Europe To Tourists BY Associated Press
Making A Difference Despite Evidence Of Rare Blood Clot Risk, US To Resume Use Of J&J’s Covid-19 Vaccine BY Associated Press
National Remdesivir An 'Investigational Drug', Not Suitable For Home Use: Niti Aayog BY Outlook Web Bureau
Making A Difference US: Johnson & Johnson Begins Testing Covid-19 Vaccines On Teenagers BY Associated Press
Making A Difference J&J To Pay Rs 890 Cr To Woman Who Alleged Company’s Talcum Powder Contains Cancerous Agents BY Outlook Web Bureau